Does OLUTASIDENIB Cause Off label use? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Off label use have been filed in association with OLUTASIDENIB (REZLIDHIA). This represents 28.1% of all adverse event reports for OLUTASIDENIB.
59
Reports of Off label use with OLUTASIDENIB
28.1%
of all OLUTASIDENIB reports
3
Deaths
18
Hospitalizations
How Dangerous Is Off label use From OLUTASIDENIB?
Of the 59 reports, 3 (5.1%) resulted in death, 18 (30.5%) required hospitalization, and 1 (1.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLUTASIDENIB. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does OLUTASIDENIB Cause?
Hospitalisation (27)
Death (24)
Nausea (23)
Fatigue (21)
Product dose omission issue (19)
Product prescribing issue (15)
Constipation (14)
Transfusion (11)
Pneumonia (9)
Asthenia (7)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which OLUTASIDENIB Alternatives Have Lower Off label use Risk?
OLUTASIDENIB vs OMACETAXINE MEPESUCCINATE
OLUTASIDENIB vs OMADACYCLINE
OLUTASIDENIB vs OMALIZUMAB
OLUTASIDENIB vs OMAVELOXOLONE
OLUTASIDENIB vs OMBITASVIR